{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:40:34Z","timestamp":1781023234370,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ebr.2025.100741","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T22:16:21Z","timestamp":1736979381000},"page":"100741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The use of newer anti-seizure medicines in women with epilepsy in pregnancy: A case series"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-8320","authenticated-orcid":false,"given":"Joan E.","family":"Devin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muskan","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2025.100741_b0005","unstructured":"Knight M, Bunch K, Felker A, et al., editors. on behalf of MBRRACE-UK. Saving Lives, Improving Mothers\u2019 Care Core Report - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2019-21. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2023."},{"key":"10.1016\/j.ebr.2025.100741_b0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ebr.2025.100741_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2025.100741_b0020","unstructured":"Medicines and Healthcare products. Antiepileptic drugs: Review of Safety of Use During Pregnancy. MHRA Public Assessment Report, January 2021. https:\/\/www.gov.uk\/government\/publications\/public-assesment-report-of-antiepileptic-drugs-review-of-safety-of-use-during-pregnancy (accessed 29 December 2024)."},{"key":"10.1016\/j.ebr.2025.100741_b0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamaneurol.2023.0148","article-title":"Comparison of Perinatal Outcomes for Women With and Without Epilepsy: A Systematic Review and Meta-analysis","volume":"80","author":"Mazzone","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebr.2025.100741_b0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074630","article-title":"Management of epilepsy during pregnancy and lactation","author":"Hope","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ebr.2025.100741_b0035","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1528-1167.2009.02093.x","article-title":"Utilization of antiepileptic drugs during pregnancy: Comparative patterns in 38 countries based on data from the EURAP registry","volume":"50","author":"Eurap Study Group.","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100741_b0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/ppe.12004","article-title":"Trends in the use of antiepileptic drugs among pregnant women in the US, 2001\u20132007: a medication exposure in pregnancy risk evaluation program study","volume":"26","author":"Bobo","year":"2012","journal-title":"Paediatric Perinatal Epid"},{"key":"10.1016\/j.ebr.2025.100741_b0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13181-017-0626-4","article-title":"The pharmacology and toxicology of third-generation anticonvulsant drugs","volume":"13","author":"LaPenna","year":"2017","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.ebr.2025.100741_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108549","article-title":"Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands","volume":"127","author":"Houben","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2025.100741_b0055","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221101687","article-title":"Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide","volume":"15","author":"Nucera","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ebr.2025.100741_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.seizure.2023.02.015","article-title":"Increasing use of newer antiseizure medication during pregnancy: an observational study with special focus on lacosamide","volume":"107","author":"Hoeltzenbein","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2025.100741_b0065","first-page":"469","article-title":"Maternal mortality in women with epilepsy","volume":"109","author":"Holohan","year":"2016","journal-title":"IMJ"},{"key":"10.1016\/j.ebr.2025.100741_b0070","doi-asserted-by":"crossref","unstructured":"Munn Z, Barker TH, Moola S, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database of Systematic Reviews and Implementation Reports. 2019; Publish Ahead of Print. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099.","DOI":"10.11124\/JBISRIR-D-19-00099"},{"key":"10.1016\/j.ebr.2025.100741_b0075","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.ebr.2025.100741_b0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100741_b0085","doi-asserted-by":"crossref","unstructured":"Morris RK, Johnstone E, Lees C, et al. Investigation and Care of a Small\u2010for\u2010Gestational\u2010Age Fetus and a Growth Restricted Fetus (Green\u2010top Guideline No. 31). BJOG. 2024;131. https:\/\/doi.org\/10.1111\/1471-0528.17814.","DOI":"10.1111\/1471-0528.17814"},{"key":"10.1016\/j.ebr.2025.100741_b0090","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2023"},{"key":"10.1016\/j.ebr.2025.100741_b0095","doi-asserted-by":"crossref","first-page":"e2314","DOI":"10.1002\/bdr2.2314","article-title":"EUROCAT guidelines for classification of cases with congenital anomalies","volume":"116","author":"Bergman","year":"2024","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.ebr.2025.100741_b0100","unstructured":"Health Products Regulatory Authority. Topiramate (Topamax) pregnancy prevention programme and restrictions on use. 2023. https:\/\/www.hpra.ie\/homepage\/medicines\/special-topics\/topiramate-(topamax-)-pregnancy-prevention-programme-and-restrictions-on-use (accessed 29 December 2024)."},{"key":"10.1016\/j.ebr.2025.100741_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.12688\/hrbopenres.13625.1","article-title":"Estimating the costs associated with the implementation of a best practice model of care for recurrent miscarriage clinics in Ireland: a cost analysis","volume":"5","author":"Flannery","year":"2022","journal-title":"HRB Open Res"},{"key":"10.1016\/j.ebr.2025.100741_b0110","article-title":"Miscarriage hospitalisations: a national population-based study of incidence and outcomes","volume":"2019;16:51","author":"San Lazaro Campillo","year":"2005","journal-title":"Reprod Health"},{"key":"10.1016\/j.ebr.2025.100741_b0115","doi-asserted-by":"crossref","unstructured":"Regan L, Rai R, Saravelos S, et al. Recurrent Miscarriage. Green\u2010top Guideline No. 17. BJOG. 2023;130. https:\/\/doi.org\/10.1111\/1471-0528.17515.","DOI":"10.1111\/1471-0528.17515"},{"key":"10.1016\/j.ebr.2025.100741_b0120","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","article-title":"Maternal age and fetal loss: population based register linkage study","volume":"320","author":"Nybo Andersen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ebr.2025.100741_b0125","unstructured":"Healthcare Pricing Office, Health Service Executive. Perinatal Statistics Report 2021. Dublin 2024. https:\/\/www.hpo.ie\/latest_hipe_nprs_reports\/NPRS_2021\/Perinatal_Statistics_Annual_Report_2021.pdf (accessed 29 December 2024)."},{"key":"10.1016\/j.ebr.2025.100741_b0130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ebr.2025.100741_b0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ane.13222","article-title":"Outcomes in three cases after brivaracetam treatment during pregnancy","volume":"141","author":"Paolini","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ebr.2025.100741_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.09.005","article-title":"An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam","volume":"52","author":"Yates","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2025.100741_b0145","unstructured":"Royal College of Obstetricians and Gynaecologists. Epilepsy in Pregnancy. Green-top Guideline No. 68. 2016. https:\/\/www.rcog.org.uk\/media\/rzldnacf\/gtg68_epilepsy.pdf (accessed December 2024)."},{"key":"10.1016\/j.ebr.2025.100741_b0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2021.07.002","article-title":"Zonisamide safety in pregnancy: Data from the UK and Ireland epilepsy and pregnancy register","volume":"91","author":"McCluskey","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2025.100741_b0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2021.07.030","article-title":"Teratogenic effects of zonisamide","volume":"91","author":"Vajda","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.ebr.2025.100741_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000000018","article-title":"Association between topiramate and zonisamide use during pregnancy and low birth weight","volume":"123","author":"Hern\u00e1ndez-D\u00edaz","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ebr.2025.100741_b0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/epd2.20146","article-title":"Thirteen years of experience with eslicarbazepine acetate in the United Kingdom and Republic of Ireland: a safety perspective","volume":"25","author":"Guedes","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ebr.2025.100741_b0170","unstructured":"World Health Organization. Standards for Maternal and Neonatal Care. 2007. https:\/\/iris.who.int\/bitstream\/handle\/10665\/69735\/a91272.pdf (accessed 29 December 2024)."},{"key":"10.1016\/j.ebr.2025.100741_b0175","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebr.2025.100741_b0180","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaneurol.2022.2977","article-title":"Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy","volume":"79","author":"Vegrim","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebr.2025.100741_b0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/15357597221147357","article-title":"Too much of a good thing? High-dose folic acid in pregnancy and childhood cancer","volume":"23","author":"Gerard","year":"2023","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.ebr.2025.100741_b0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10309-023-00602-3","article-title":"Pregnancy, folic acid, and antiseizure medication","volume":"36","author":"Bj\u00f8rk","year":"2023","journal-title":"Clin Epileptol"},{"key":"10.1016\/j.ebr.2025.100741_b0195","unstructured":"First Do No Harm: The report of the Independent Medicines and Medical Devices Safety Review. United Kingdom: Independent Medicines and Medical Devices Safety Review 2020. https:\/\/www.immdsreview.org.uk\/Report.html (accessed 29 December 2024)."},{"key":"10.1016\/j.ebr.2025.100741_b0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(15)00398-1","article-title":"The remarkable story of valproic acid","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol"}],"container-title":["Epilepsy &amp; Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986425000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986425000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:17:10Z","timestamp":1751977030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986425000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"alternative-id":["S2589986425000012"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2025.100741","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of newer anti-seizure medicines in women with epilepsy in pregnancy: A case series","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2025.100741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100741"}}